(Q40840106)

24 September 2017

title

Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial (English)

1 reference

24 September 2017

Oral antibiotic prophylaxis in patients with cancer: A double-blind randomized placebo-controlled trial (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(83)80310-2

1 October 2023

0 references

P. A. Pizzo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336781

1 October 2023

K. J. Robichaud

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336781

1 October 2023

B. K. Edwards

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336781

1 October 2023

C. Schumaker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336781

1 October 2023

B. S. Kramer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336781

1 October 2023

A. Johnson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336781

1 October 2023

language of work or name

English

0 references

publication date

1 January 1983

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:S0022347683803102?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(83)80310-2

https://api.elsevier.com/content/article/PII:S0022347683803102?httpAccept=text/plain

1 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(83)80310-2

The Journal of Pediatrics

1 October 2023

published in

1 reference

24 September 2017

volume

102

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

125-133

1 reference

Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Infection prevention during profound granulocytopenia. New approaches to alimentary canal microbial suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Infectious complications in the child with cancer. III. Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

The value of protective isolation in preventing nosocomial infections in high risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Colonization resistance of the digestive tract of mice during systemic antibiotic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Trimethoprim-sulfamethoxazole in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

The randomization and stratification of patients to clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Emergence of trimethoprim-resistant enterobacteria in patients receiving long-term co-trimoxazole for the control of intractable urinary-tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Pancytopenia in an infant associated with sulfamethoxazole-trimethoprim therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Trimethoprim and Sulphamethoxazole Inhibition of Haematopoiesis in Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Influence of co-trimoxazole on methotrexate pharmacokinetics in children with acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

Randomized trial of protected environment--prophylactic antibiotics in 145 adults with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980310-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Effect of trimethoprim-sulfamethoxazole on hematological recovery after total body irradiation and autologous marrow infusion in dogs

35

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(83)80310-2

1 October 2023

Identifiers

1 reference

24 September 2017

1 reference